These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15209176)

  • 1. Reflections on the social epidemiologic dimension of health technology assessment.
    Kazanjian A
    Int J Technol Assess Health Care; 2004; 20(2):167-73. PubMed ID: 15209176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology assessment and the sociopolitics of health technologies.
    Lehoux P; Blume S
    J Health Polit Policy Law; 2000 Dec; 25(6):1083-120. PubMed ID: 11142053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health technology assessment: a comprehensive framework for evidence-based recommendations in Ontario.
    Johnson AP; Sikich NJ; Evans G; Evans W; Giacomini M; Glendining M; Krahn M; Levin L; Oh P; Perera C
    Int J Technol Assess Health Care; 2009 Apr; 25(2):141-50. PubMed ID: 19366496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTA responses and the classic HTA report.
    Milne R; Clegg A; Stevens A
    J Public Health Med; 2003 Jun; 25(2):102-6. PubMed ID: 12848397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social and ethical analysis in health technology assessment.
    Tantivess S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S81-6. PubMed ID: 24964703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded HTA: Enhancing Fairness and Legitimacy.
    Daniels N; Porteny T; Urritia J
    Int J Health Policy Manag; 2015 Nov; 5(1):1-3. PubMed ID: 26673643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology assessment. Old, new, and needs-based.
    Tugwell P; Sitthi-Amorn C; O'Connor A; Hatcher-Roberts J; Bergevin Y; Wolfson M
    Int J Technol Assess Health Care; 1995; 11(4):650-62. PubMed ID: 8567197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
    Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.
    Feig C; Cheung KL; Hiligsmann M; Evers SMAA; Simon J; Mayer S
    Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):223-232. PubMed ID: 28862060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community views and perspectives on public engagement in health technology assessment decision making.
    Wortley S; Tong A; Howard K
    Aust Health Rev; 2017 Mar; 41(1):68-74. PubMed ID: 27050156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social values and health priority setting in Australia: an analysis applied to the context of health technology assessment.
    Whitty JA; Littlejohns P
    Health Policy; 2015 Feb; 119(2):127-36. PubMed ID: 25267072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health technology assessment in Saudi Arabia.
    Al-Aqeel S
    Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):393-402. PubMed ID: 29733227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding Health Technology Assessments to Include Effects on the Environment.
    Marsh K; Ganz ML; Hsu J; Strandberg-Larsen M; Gonzalez RP; Lund N
    Value Health; 2016; 19(2):249-54. PubMed ID: 27021760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health technology assessment in its local contexts: studies of telehealthcare.
    May C; Mort M; Williams T; Mair F; Gask L
    Soc Sci Med; 2003 Aug; 57(4):697-710. PubMed ID: 12821017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for successful evaluation and policy-making toward health care technology on the move: the case of medical lasers.
    Banta HD; Vondeling H
    Soc Sci Med; 1994 Jun; 38(12):1663-74. PubMed ID: 8047925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of health technology assessment in China: New challenges.
    Chen Y; He Y; Chi X; Wei Y; Shi L
    Biosci Trends; 2018; 12(2):102-108. PubMed ID: 29760354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HTA Core Model
    Kristensen FB; Lampe K; Wild C; Cerbo M; Goettsch W; Becla L
    Value Health; 2017 Feb; 20(2):244-250. PubMed ID: 28237203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ethical analysis in conducting a health technology assessment of medical treatments for gender dysphoria.
    Saarni SI; Uusitalo S; Autti-Rämö I
    Int J Technol Assess Health Care; 2022 Nov; 38(1):e82. PubMed ID: 36373501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.